伟思医疗 (688580.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

19.5x

Market Cap

CNY 4.38B

MomentumView details →

1D Return

−5.31%

YTD Return

—

RSI (14)

36.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

19.5x

Market Cap

CNY 4.38B

RSI (14)

36.9

MomentumView details →

1D Return

−5.31%

YTD Return

—

ProfitabilityView details →

Gross Margin

66.09%

Net Margin

35.20%

EBITDA Margin

38.11%

ROE (TTM)

9.48%

ROA (TTM)

8.93%

Asset Turnover

0.25x

GrowthView details →

Revenue YoY

+15.81%

EPS YoY

+45.51%

FCF YoY

−78.17%

Revenue CAGR 3Y

+12.89%

EPS CAGR 3Y

+1.58%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.41

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

0.00%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

9.65x

Quick Ratio

9.31x

Div Yield

2.44%

Div Rate

CNY 1.08

Div Growth 1Y

+35.25%

Financials snapshotView financials →

Revenue (TTM)

472.85M

Net Income (TTM)

166.43M

Op. CF (TTM)

170.24M

Next earningsOct 22, 2026 →

Latest newsMore news →

Weisi Medical announced that shareholder Hu Ping plans to reduce his stake by up to 2% of total shares through block trades and centralized bidding between September 24 and December 22, 2026.3d ago

Weisi Medical announced its H1 2026 results with revenue of 226 million yuan, up 7.59% year-on-year, and net profit of 100 million yuan, up 44.43% year-on-year.11d ago

Similar companies

Integer Holdings CorporationITGR LivaNova PLCLIVN MicroPort NeuroTech Limited02172.HK 基蛋生物603387.SH iRhythm Technologies, Inc.IRTC 三友医疗688085.SH Find similar companies →

Latest newsMore news →

Weisi Medical announced that shareholder Hu Ping plans to reduce his stake by up to 2% of total shares through block trades and centralized bidding between September 24 and December 22, 2026.3d ago Weisi Medical announced its H1 2026 results with revenue of 226 million yuan, up 7.59% year-on-year, and net profit of 100 million yuan, up 44.43% year-on-year.11d ago